Clinical research is crucial for national cancer control plans. Prior to the Russian invasion on 24th Feb 2022 both Russia and Ukraine were significant contributors to global clinical trials and cancer research. In this short analysis we describe this and the impact that the conflict has had with wider consideration for the global cancer research ecosystems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejca.2023.01.020 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!